Literature DB >> 3958499

Potentiation of hybridoma production by the use of mouse fibroblast conditioned media.

K Z Walker, J Gibson, S M Axiak, R L Prentice.   

Abstract

L-CM is a conditioned medium prepared from cultures of L-929 cells, a murine fibroblast line. It will promote the growth and antibody secretion of B cell hybridomas after fusion as well as facilitating cloning at limit dilution and the growth of cloned B cell lines in bulk culture. The medium is easy to prepare and stores well at 4 degrees C. It thus provides a convenient alternative to the use of feeder cells in the production of monoclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3958499     DOI: 10.1016/0022-1759(86)90053-0

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  5 in total

1.  A Bioassay for Optimization of Macrophage-Conditioned Medium as a Culture Supplement to Promote Hybridoma Cell Survival and Growth.

Authors:  Robert Hnasko; Alice V Lin; Larry Stanker; Jeffery McGarvey
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2018-06-14

2.  Improvement in the proliferative activity of human-human hybridomas at low cell density by transfection with bFGF gene.

Authors:  K Iwamoto; Y Shintani; H Sawada; K Kitano
Journal:  Cytotechnology       Date:  1991-06       Impact factor: 2.058

3.  Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor.

Authors:  C A Hanham; F Zhao; G H Tignor
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

4.  Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

Authors:  J Van Snick; S Cayphas; A Vink; C Uyttenhove; P G Coulie; M R Rubira; R J Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

5.  Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.

Authors:  J Van Snick; A Vink; S Cayphas; C Uyttenhove
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.